Vice President, Public Affairs
In January 2017 Alex joined Gilead Sciences as Vice President for Public Affairs
responsible for all communications and patient advocacy activities across Europe, Middle
East and Australia. Alex has held senior communication roles with a number of
consumer and pharmaceutical companies including Unilever, Rolls Royce, Novartis,
Roche, Astrazeneca and GlaxoSmithKline. Before he was drawn into the communications
world, Alex started his career as a Biochemical engineer.
He is passionate about diversity and inclusion and especially LGBTQ+ rights. For
example, Alex has been instrumental on a partnership with the Elton John AIDS
Foundation’s Eastern Europe and Central Asia Key Populations Fund, which supports
LGBTQ+ NGOs across the Eastern Europe region in order to reduce stigma associated
with being a member of the LGBTQ+ community and being HIV positive. He has been
the Executive Sponsor of the LGBTQ+ ERG in his previous company Rolls Royce
Aerospace and he continues to sponsor the LGBTQ+ ERG at Gilead as well.
Alex has been recognised by the Financial Times as the OUTstanding top 100 LGBT+
Executives for 2018. OUTstanding is an organisation for global businesses working
directly with LGBTQ+ and ally leaders to drive cultural change, creating an environment
where everyone can succeed.